UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000030056
Receipt No. R000034320
Scientific Title A phase II trial of Decompression Surgery and Postoperative Stereotactic Body Radiotherapy for Metastatic Epidural Spinal Cord Compression
Date of disclosure of the study information 2017/11/21
Last modified on 2018/11/23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A phase II trial of
Decompression Surgery and Postoperative Stereotactic Body Radiotherapy for Metastatic Epidural Spinal Cord Compression
Acronym Decompression Surgery and Postoperative SBRT for MESCC
Scientific Title A phase II trial of
Decompression Surgery and Postoperative Stereotactic Body Radiotherapy for Metastatic Epidural Spinal Cord Compression
Scientific Title:Acronym Decompression Surgery and Postoperative SBRT for MESCC
Region
Japan

Condition
Condition Metastatic Epidural Spinal Cord Compression
Classification by specialty
Radiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the efficacy and toxicity of decompression surgery and postoperative stereotactic body radiotherapy for metastatic epidural spinal cord compression.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Local control at 1 year
Key secondary outcomes Ambulatory function, OS, local progression free survival, pattern of failure, pain response, Adverse events, QOL

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment No need to know

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Device,equipment
Interventions/Control_1 Surgical decompression and postoperative stereotactic body radiotherapy of 24 Gy in 2 fractions.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1. pathological or clinical diagnosis of primary cancer (including sarcoma)
2. spine metastases confirmed by images
3. Symptoms by the tumor
4. Bilsky grade is more than Ib
5. Age; 20-
6. Other lesions are controlled, or the lesion was irradiated previously
7. prognosis is expected more than 6 months
8. Written informed consent
Key exclusion criteria 1. Radiosensitive histology
2. the lesion was irradiated within 3 months
3. the lesion was treated with SBRT
4. untlerable to surgery
5. complete paralysis more than 48 hours
6. impossible to conduct decompression surgery
Target sample size 33

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Takahiro Hozumi
Organization Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
Division name Orthopedic surgery
Zip code
Address 3-18-22 Honkomagome, Bunkyo-ku,Tokyo
TEL 03-3823-2101
Email t.hoz@cick.jp

Public contact
Name of contact person
1st name
Middle name
Last name Kei Ito
Organization Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
Division name Division of Radiation Oncology, Department of Radiology
Zip code
Address 3-18-22 Honkomagome, Bunkyo-ku,Tokyo
TEL 03-3823-2101
Homepage URL http://www.cick.jp/houshasenchiryou/housha_shiken/
Email keiito@cick.jp

Sponsor
Institute Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 11 Month 21 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2017 Year 10 Month 10 Day
Date of IRB
Anticipated trial start date
2017 Year 11 Month 20 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2017 Year 11 Month 21 Day
Last modified on
2018 Year 11 Month 23 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034320

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.